TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C Reply

被引：0
|
作者：
Matsuura, Kentaro [1 ]
Kurosaki, Masayuki [2 ]
Tanaka, Yasuhito [3 ,4 ]
机构：
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan
[2] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
[4] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan
来源：
GASTROENTEROLOGY | 2017年 / 153卷 / 05期
关键词：
D O I：
10.1053/j.gastro.2017.10.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1449 / 1450
页数：3
相关论文
共 50 条
  • [1] TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C
    John, Miya
    Metwally, Mayada
    Mangia, Alessandra
    Romero-Gomez, Manuel
    Berg, Thomas
    Sheridan, David
    George, Jacob
    Eslam, Mohammed
    GASTROENTEROLOGY, 2017, 153 (05) : 1448 - 1449
  • [2] Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
    Agwa, Sara H. A.
    Kamel, Marwa Mostafa
    Elghazaly, Hesham
    Abd Elsamee, Aya M.
    Hafez, Hala
    Girgis, Samia Abdo
    Elarab, Hoda Ezz
    Ebeid, Fatma S. E.
    Sayed, Safa Matbouly
    Sherif, Lina
    Matboli, Marwa
    GENES, 2021, 12 (06)
  • [3] Association of TLL1 Variant with Development of Hepatocellular Carcinoma and Fibrosis after Eradication of Hepatitis C Virus
    Iio, Etsuko
    Matsuura, Kentaro
    Shimada, Noritomo
    Atsukawa, Masanori
    Takaguchi, Koichi
    Eguchi, Yuichiro
    Nomura, Hideyuki
    Miyaki, Tomokatsu
    Kusakabe, Atsunori
    Kato, Keizo
    Hirashima, Noboru
    Matsunami, Kayoko
    Fujiwara, Kei
    Tanaka, Yasuhito
    HEPATOLOGY, 2018, 68 : 917A - 918A
  • [4] Fibrosis Progression in African Americans and Caucasian Americans With Chronic Hepatitis C
    Terrault, Norah A.
    Im, Kelly
    Boylan, Ross
    Bacchetti, Peter
    Kleiner, David E.
    Fontana, Robert J.
    Hoofnagle, Jay H.
    Belle, Steven H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (12) : 1403 - 1411
  • [5] Association of TLL1 Polymorphism with Development of Hepatocellular Carcinoma after Hepatitis C Virus Eradication and Fibrosis Severity
    Miki, Daiki
    Kawaoka, Tomokazu
    Yuko, Nagaoki
    Hayes, Nelson
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Aikata, Hiroshi
    Abe-Chayama, Hiromi
    Ochi, Hidenori
    Tsunoda, Tatsuhiko
    Chayama, Kazuaki
    HEPATOLOGY, 2018, 68 : 597A - 597A
  • [6] A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B
    El Sharkawy, R.
    Thabet, K.
    Lampertico, P.
    Petta, S.
    Mangia, A.
    Berg, T.
    Metwally, M.
    Bayoumi, A.
    Boonstra, A.
    Brouwer, W. P.
    Smedile, A.
    Abate, M. L.
    Loglio, A.
    Douglas, M. W.
    Khan, A.
    Santoro, R.
    Fischer, J.
    Leeming, D. J.
    Liddle, C.
    George, J.
    Eslam, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (05) : 564 - 573
  • [7] Hepatitis C Increases the Risk of Progression of Chronic Kidney Disease in Patients with Glomerulonephritis
    Noureddine, Lama A.
    Usman, Sohail A.
    Yu, Zhangsheng
    Moorthi, Ranjani N.
    Moe, Sharon M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (04) : 311 - 316
  • [8] Fibrosis progression in chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus Reply
    Tommasini Grotto, Rejane Maria
    de Moura Campos Pardini, Maria Ines
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2016, 49 (06) : 806 - 807
  • [9] Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
    Poynard, T
    Ratziu, V
    Charlotte, F
    Goodman, Z
    McHutchison, J
    Albrecht, J
    JOURNAL OF HEPATOLOGY, 2001, 34 (05) : 730 - 739
  • [10] Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B
    Miller, M.
    Heron, T.
    Dillon, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1236 - 1236
12345